Taste Evaluation of Different Liquid Formulations With Eliglustat

NCT02422654 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher Disease

Interventions

DRUG: eliglustat

Sponsor

Genzyme, a Sanofi Company